Concepedia

Publication | Open Access

Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease

173

Citations

33

References

2022

Year

Abstract

ClinicalTrials.gov Identifier: NCT03289143.

References

YearCitations

Page 1